Abstract is: Anne Peters is a endocrinologist, diabetes expert, and professor of clinical medicine at the Keck School of Medicine of USC. She runs diabetes centers in well-served Beverly Hills and under-resourced East Los Angeles. She teaches physicians and people with diabetes around the world how to better treat the condition, through lifestyle, medications and technology.
| human | Q5 |
| P2671 | Google Knowledge Graph ID | /g/11f_bz_b30 |
| P496 | ORCID iD | 0000-0003-0520-0776 |
| P1153 | Scopus author ID | 7402105843 |
| P69 | educated at | University of Chicago | Q131252 |
| Wesleyan University | Q49167 | ||
| P108 | employer | University of Southern California | Q4614 |
| UCLA Ronald Reagan Medical Center | Q2169282 | ||
| P734 | family name | Peters | Q2079518 |
| Peters | Q2079518 | ||
| Peters | Q2079518 | ||
| P735 | given name | Anne | Q564684 |
| Anne | Q564684 | ||
| P106 | occupation | researcher | Q1650915 |
| P21 | sex or gender | female | Q6581072 |
| Q34214446 | "We are all gonna get diabetic these days": the impact of a living legacy of type 2 diabetes on Hispanic young adults' diabetes care |
| Q57412690 | A Clinical Approach for the Diagnosis of Diabetes Mellitus |
| Q114254696 | A Glycemia Risk Index (GRI) of Hypoglycemia and Hyperglycemia for Continuous Glucose Monitoring Validated by Clinician Ratings |
| Q51578971 | A clinical approach for the diagnosis of diabetes mellitus: an analysis using glycosylated hemoglobin levels. Meta-analysis Research Group on the Diagnosis of Diabetes Using Glycated Hemoglobin Levels. |
| Q40031773 | A mobile health intervention for inner city patients with poorly controlled diabetes: proof-of-concept of the TExT-MED program |
| Q39888615 | A piece of my mind. Clinic of tears |
| Q57483085 | Advances in Glucose Monitoring and Automated Insulin Delivery: Supplement to Endocrine Society Clinical Practice Guidelines |
| Q43899865 | An intervention for enhancing compliance with screening recommendations for diabetic retinopathy. A bicoastal experience |
| Q41519191 | An overview of metformin in the treatment of type 2 diabetes mellitus |
| Q57412688 | Antihypertensive Agents in Diabetic Patients |
| Q47883795 | Application of a diabetes managed care program. The feasibility of using nurses and a computer system to provide effective care |
| Q36350029 | Association between use of warfarin with common sulfonylureas and serious hypoglycemic events: retrospective cohort analysis |
| Q46383152 | Authors' reply to Bosco-Lévy and Salvo |
| Q38580750 | BIOSIMILARS AND NEW INSULIN VERSIONS. |
| Q92695630 | Baseline nocturnal glucose change: A predictor of the treatment effect of bolus intensification in insulin-treated type 2 diabetes |
| Q35060170 | Benefits of modest weight loss in improving cardiovascular risk factors in overweight and obese individuals with type 2 diabetes |
| Q24632375 | Beyond the monofilament for the insensate diabetic foot: a systematic review of randomized trials to prevent the occurrence of plantar foot ulcers in patients with diabetes |
| Q30548796 | Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes |
| Q37224960 | Cardiovascular health: associations with race-ethnicity, nativity, and education in a diverse, population-based sample of Californians |
| Q46482950 | Case study 2: new insights: clinical pearls for using incretin mimetics in type 2 diabetes |
| Q34459281 | Challenges contributing to disrupted transition from paediatric to adult diabetes care in young adults with type 1 diabetes |
| Q45179727 | Challenges in applying diabetes technology to clinical care |
| Q110661550 | Characteristics of Adult vs. Childhood-Onset Type 1 Diabetes (T1D) in the T1D Exchange Registry |
| Q46342421 | Characteristics of youth with type 1 diabetes (T1D) with and without a parent with T1D in the T1D exchange clinic registry |
| Q36153812 | Clinical and Economic Impact of a Digital, Remotely-Delivered Intensive Behavioral Counseling Program on Medicare Beneficiaries at Risk for Diabetes and Cardiovascular Disease |
| Q46085986 | Clinical and Psychosocial Outcomes of a Structured Transition Program Among Young Adults With Type 1 Diabetes |
| Q43224161 | Clinical and behavioral correlates of achieving and maintaining glycemic targets in an underserved population with type 2 diabetes |
| Q37242652 | Clinical application of emerging sensor technologies in diabetes management: consensus guidelines for continuous glucose monitoring (CGM). |
| Q34627378 | Considerations for treating dyslipidemia in special diabetic populations |
| Q37192472 | Continuous glucose monitoring pilot in low-income type 1 diabetes patients |
| Q38077833 | Cost, healthcare resource utilization, and adherence of individuals with diabetes using U-500 or U-100 insulin: a retrospective database analysis |
| Q36769844 | Cost-effective screening for diabetic retinopathy using a nonmydriatic retinal camera in a prepaid health-care setting. |
| Q46686547 | Death and medicine: a personal account |
| Q43824997 | Depression in adults in the T1D Exchange Clinic Registry |
| Q57412676 | Diabetes Disease Management: Past, Present, and Future |
| Q57412627 | Diabetes Empowerment Council (DEC): Development and Pilot Testing of an Innovative Mind-Body Group Intervention for Young Adults with Type 1 Diabetes |
| Q38944771 | Diabetes Technology-Continuous Subcutaneous Insulin Infusion Therapy and Continuous Glucose Monitoring in Adults: An Endocrine Society Clinical Practice Guideline |
| Q57412620 | Diabetes and Cardiovascular Disease Risk Factors as Influenced by Race and Ethnic Background |
| Q26865504 | Diabetes care for emerging adults: recommendations for transition from pediatric to adult diabetes care systems: a position statement ... |
| Q41946094 | Diabetes distress in adults with type 1 diabetes: Prevalence, incidence and change over time |
| Q57412656 | Diabetes in Women: Pathophysiology and Therapy |
| Q37444781 | Diabetes management for low-income patients in Los Angeles: two strategies improved disease control in the short term |
| Q38893535 | Diabetic Ketoacidosis With Canagliflozin, a Sodium-Glucose Cotransporter 2 Inhibitor, in Patients With Type 1 Diabetes |
| Q99417337 | Diabetic Ketoacidosis and Related Events With Sotagliflozin Added to Insulin in Adults With Type 1 Diabetes: A Pooled Analysis of the inTandem 1 and 2 Studies |
| Q57412681 | Diagnosing diabetes in 2000 |
| Q57412684 | Diagnosing diabetes in 2000 |
| Q34073494 | Do experiences consistent with a medical-home model improve diabetes care measures reported by adult Medicaid patients? |
| Q45996441 | Do we really need continuous glucose monitoring? |
| Q37638873 | Durability of glycemic control with insulin lispro mix 75/25 versus insulin glargine for older patients with type 2 diabetes |
| Q57412700 | Early Parenteral Nutrition in Patients Unconscious Because of Acute Drug Poisoning |
| Q36133698 | Effect of 1 year of an intentional weight loss intervention on bone mineral density in type 2 diabetes: results from the Look AHEAD randomized trial |
| Q44980828 | Effect of isocaloric substitution of chocolate cake for potato in type I diabetic patients |
| Q89690918 | Efficacy and safety of dual add-on therapy with dapagliflozin plus saxagliptin versus glimepiride in patients with poorly controlled type 2 diabetes on a stable dose of metformin: Results from a 52-week, randomized, active-controlled trial |
| Q35973255 | Euglycemic Diabetic Ketoacidosis: A Potential Complication of Treatment With Sodium-Glucose Cotransporter 2 Inhibition |
| Q36444054 | Exenatide therapy and the risk of pancreatitis and pancreatic cancer in a privately insured population |
| Q39105419 | Exercise management in type 1 diabetes: a consensus statement |
| Q40232752 | Food and park environments: neighborhood-level risks for childhood obesity in east Los Angeles |
| Q38836509 | Four-Year Physical Activity Levels among Intervention Participants with Type 2 Diabetes |
| Q45199827 | GLP-1 provoked severe hypoglycemia in an individual with type 2 diabetes and a benign insulinoma |
| Q44533647 | Healthcare costs and adherence associated with human regular U-500 versus high-dose U-100 insulin in patients with diabetes |
| Q38780319 | Hypoglycemia in Older Adults with Type 1 Diabetes |
| Q37612448 | Immigration disparities in cardiovascular disease risk factor awareness |
| Q34073450 | Impact of an intensive lifestyle intervention on use and cost of medical services among overweight and obese adults with type 2 diabetes: the action for health in diabetes |
| Q39826453 | Increasing Patient Acceptance and Adherence Toward Insulin |
| Q33537570 | Incretin-based therapies: review of current clinical trial data. |
| Q37089158 | Insulin plus a Sulfonylurea Agent for Treating Type 2 Diabetes |
| Q38382412 | Insulin pump risks and benefits: a clinical appraisal of pump safety standards, adverse event reporting and research needs. A joint statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Techno |
| Q38380007 | Insulin pump risks and benefits: a clinical appraisal of pump safety standards, adverse event reporting, and research needs: a joint statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Techn |
| Q27001931 | Intensification of insulin therapy in patients with type 2 diabetes mellitus: an algorithm for basal-bolus therapy |
| Q34010035 | Intensive weight loss intervention in older individuals: results from the Action for Health in Diabetes Type 2 diabetes mellitus trial |
| Q51314081 | Is insulin the most effective injectable antihyperglycaemic therapy? |
| Q57412704 | Lack of glucose elevation after simulated tube feeding with a low-carbohydrate, high-fat enteral formula in patients with type I diabetes |
| Q35881430 | Let's Empower and Prepare (LEAP): Evaluation of a Structured Transition Program for Young Adults With Type 1 Diabetes |
| Q35537662 | Long-term outcomes of a Web-based diabetes prevention program: 2-year results of a single-arm longitudinal study |
| Q34726517 | Male anorgasmia treated with oxytocin |
| Q34457919 | Management of hyperglycaemia in type 2 diabetes, 2015: a patient-centred approach. Update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes |
| Q57412648 | Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) |
| Q28254549 | Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes |
| Q55197858 | Management of hyperglycemia in type 2 diabetes: a patient-centered approach. Position Statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 2012;35:1364–1379. |
| Q22241288 | Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). |
| Q38020016 | Managing diabetes in the middle-aged patient when loss of glycemic control occurs |
| Q37642385 | Patient and treatment perspectives: Revisiting the link between type 2 diabetes, weight gain, and cardiovascular risk |
| Q35009757 | Patient perspectives on peer mentoring: type 1 diabetes management in adolescents and young adults |
| Q44530027 | Prevalence of depression in Type 1 diabetes and the problem of over-diagnosis. |
| Q41676427 | Prevalence of detectable C-Peptide according to age at diagnosis and duration of type 1 diabetes |
| Q35040363 | Primary care medical home experience and health-related quality of life among adult medicaid patients with type 2 diabetes |
| Q40938430 | Quality of outpatient care provided to diabetic patients. A health maintenance organization experience |
| Q57412664 | Re-emergence of another vaccine-preventable disease?—Two cases of rubella in older adults |
| Q35360823 | Real-time continuous glucose monitoring among participants in the T1D Exchange clinic registry |
| Q53339287 | Recommendations for standardizing glucose reporting and analysis to optimize clinical decision making in diabetes: the Ambulatory Glucose Profile (AGP). |
| Q27687563 | Recommendations for standardizing glucose reporting and analysis to optimize clinical decision making in diabetes: the ambulatory glucose profile |
| Q37151277 | Reduction in weight and cardiovascular disease risk factors in individuals with type 2 diabetes: one-year results of the look AHEAD trial |
| Q51564157 | Relationship between fasting plasma glucose and glycosylated hemoglobin: potential for false-positive diagnoses of type 2 diabetes using new diagnostic criteria. |
| Q39034065 | Resilient, Empowered, Active Living with Diabetes (REAL Diabetes) study: Methodology and baseline characteristics of a randomized controlled trial evaluating an occupation-based diabetes management intervention for young adults |
| Q46059650 | Response to comment on Wong et al. Real-time continuous glucose monitoring among participants in the T1D exchange clinic registry. Diabetes Care 2014;37:2702-2709. |
| Q34746369 | Revisiting the oral glucose tolerance test criterion for the diagnosis of diabetes. |
| Q40197163 | Risk Factors Associated With Severe Hypoglycemia in Older Adults With Type 1 Diabetes |
| Q34768952 | Severe hypoglycemia and diabetic ketoacidosis in adults with type 1 diabetes: results from the T1D Exchange clinic registry |
| Q28194040 | Short and longer term outcomes of a diabetes disease management program in underserved Latino patients |
| Q39144634 | The Effect of Canagliflozin, a Sodium Glucose Cotransporter 2 Inhibitor, on Glycemic End Points Assessed by Continuous Glucose Monitoring and Patient-Reported Outcomes Among People With Type 1 Diabetes |
| Q37054706 | The Impact of Real-Time Continuous Glucose Monitoring in Patients 65 Years and Older |
| Q34219386 | The Look AHEAD Trial: bone loss at 4-year follow-up in type 2 diabetes |
| Q95814070 | The challenge of blood glucose management in diabetic patients receiving enteral or parenteral nutrition |
| Q46746029 | The new diagnostic criteria for diabetes: the impact on management of diabetes and macrovascular risk factors |
| Q30719169 | The relationship of social support with treatment adherence and weight loss in Latinos with type 2 diabetes |
| Q39999035 | The role of farmers' markets in two low income, urban communities |
| Q57412611 | Therapy of Type 1 Diabetes Mellitus |
| Q57412658 | Therapy of Type 1 Diabetes Mellitus |
| Q38440694 | Toward Development of Psychosocial Measures for Automated Insulin Delivery |
| Q42219780 | Translating the Diabetes Prevention Program into an Online Social Network: Validation against CDC Standards |
| Q46393818 | Trends in diabetes-related visits to US EDs from 1997 to 2007. |
| Q40150078 | Trial to examine text message-based mHealth in emergency department patients with diabetes (TExT-MED): a randomized controlled trial |
| Q28242092 | Type 1 diabetes through the life span: a position statement of the American Diabetes Association |
| Q40410704 | Understanding bolus insulin dose timing: the characteristics and experiences of people with diabetes who take bolus insulin |
| Q35554617 | Understanding the sources of diabetes distress in adults with type 1 diabetes |
| Q57412693 | Use of Glycosylated Hemoglobin Levels for Diagnosing Diabetes Mellitus-Reply |
| Q45184502 | Use of the Continuous Glucose Monitoring System to guide therapy in patients with insulin-treated diabetes: a randomized controlled trial |
| Q101475576 | Within-Trial Cost-Effectiveness of a Structured Lifestyle Intervention in Adults With Overweight/Obesity and Type 2 Diabetes: Results From the Action for Health in Diabetes (Look AHEAD) Study |